(Reuters) -Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce ...

Dr. Neda Azadivatan recently hosted the grand opening of her new periodontal therapy office at 3070 N. Highway 17 in North Mount Pleasant.

Doctors discuss this natural remedy that's been around for generations and whether it helps with issues including gut health, ...

Wall Street analysts were impressed by data showing competitive rates of weight loss for Viking’s therapy, but shares in the ...

Richard A. Cash died on Oct. 22 at his Cambridge home after an eight-month battle with brain cancer. He was 83.

Oral function should be measured routinely to determine individual bulbar involvement stages in spinal muscular atrophy (SMA) ...

Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...

Researchers explore the mechanisms, therapeutic potential, and clinical applications of curcumin in preventing and treating ...

Hamlet Gasoyan, MD, discussed the implications of a multiple myeloma study’s findings and their potential impact on clinical ...

Richard Cash, co-developer of the Oral Rehydration Therapy (ORT), passed away on October 22 in Boston at the age of 83, ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.